TTR

Turn Therapeutics Inc. Common Stock (TTRX) Q1 2026 Annual Earnings

TTRX·Reported May 11, 2026·Before market open

Diluted EPS came in at $-0.03, missed the $-0.02 consensus by $0.01.

Diluted EPS
$-0.03missed by $0.01
Consensus: $-0.02
SEC

SEC Filings

Earnings release8-K · 0001213900-26-054480
Annual report10-K · 0001213900-26-037505

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Turn Therapeutics Inc. Common Stock's Q1 2026 earnings report.

Turn Therapeutics Inc. Common Stock (TTRX) reported Q1 2026 earnings on May 11, 2026 before market open.

Turn Therapeutics Inc. Common Stock reported diluted EPS of $-0.03 for Q1 2026.

EPS missed the consensus estimate of $-0.02 by $0.01.

You can read the 8-K earnings release (0001213900-26-054480) and the 10-K periodic report (0001213900-26-037505) directly on SEC EDGAR. The filing index links above go to sec.gov.